NDC 69336-349

Luvira

Luvira

Luvira is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sterling-knight Pharmaceuticals, Llc. The primary component is Omega-3 Fatty Acids; 12-hydroxyeicosapentaenoic Acid, (12r)-; 4,7,10,13,16,19-docosahexaenoic Acid, (4e,7e,10e,13e,16e,19e)-.

• Product ID: 69336-349_baf70922-8fa4-491d-bd45-f0f985def69e
• NDC: 69336-349
• Product Type: Human Prescription Drug
• Proprietary Name: Luvira
• Generic Name: Luvira
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2020-01-17
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Sterling-Knight Pharmaceuticals, LLC
• Substance Name: OMEGA-3 FATTY ACIDS; 12-HYDROXYEICOSAPENTAENOIC ACID, (12R)-; 4,7,10,13,16,19-DOCOSAHEXAENOIC ACID, (4E,7E,10E,13E,16E,19E)-
• Active Ingredient Strength: 1220 mg/1; mg/1; mg/1
• Pharm Classes: Fatty Acids, Omega-3 [CS],Omega-3 Fatty Acid [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 69336-349-90

90 CAPSULE in 1 BOTTLE (69336-349-90)

• Marketing Start Date: 2020-01-17
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 69336-349-90 [69336034990]

Luvira CAPSULE

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2020-01-17

Drug Details

Active Ingredients

Ingredient	Strength
OMEGA-3 FATTY ACIDS	1220 mg/1

Pharmacological Class

• Fatty Acids
• Omega-3 [CS]
• Omega-3 Fatty Acid [EPC]

NDC Crossover Matching brand name "Luvira" or generic name "Luvira"

NDC	Brand Name	Generic Name
69336-349	Luvira	Luvira
69336-351	Luvira	Luvira